Edesa Biotech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | -6.2% | +19.9% | +5.0% | -97.5% | +1,104.5% | +106.4% | -0.5% | +55.2% | +1.4% | -35.9% | |
| – | -72.1% | -2.9% | -55.5% | +33.6% | -69.9% | +1,186.6% | +434.0% | -29.3% | -44.9% | -56.9% | +35.7% | |
| – | – | – | – | -45.6% | -42.8% | +1,186.6% | +434.0% | -29.3% | – | – | – | |
| – | -349.2% | – | – | -93.4% | -16,270.1% | – | -603.6% | – | -89.3% | +85.4% | -272.6% | |
| – | -1.6% | +46.5% | -24.7% | +26.5% | -97.9% | +324.2% | -82.1% | -8.0% | -99.9% | -100.0% | – | |
| – | – | +355.1% | +203.5% | -364.0% | – | -99.7% | -132.2% | -8.0% | – | – | – | |
| – | – | +7,060.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -93.3% | +0.0% | +0.0% | -100.0% | – | – | – | -100.0% | |
| – | -99.0% | +6,748.8% | -99.9% | +148,306.4% | -19.1% | +0.0% | +99.8% | -18.0% | -58.5% | -87.7% | +2,776.7% | |
| – | -186.4% | – | -182.2% | – | – | +31.2% | -71.3% | -219.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.